Phase IV Study of DCE-MRI Using Dotarem in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Gadoteric acid (Primary)
- Indications Liver cancer
- Focus Diagnostic use
- Acronyms DCE-MRI
- Sponsors Guerbet
- 23 Feb 2017 Planned End Date changed from 1 Dec 2016 to 1 Oct 2017.
- 19 Aug 2016 Planned End Date changed from 1 Jun 2016 to 1 Dec 2016.
- 11 Feb 2016 Planned End Date changed from 1 Aug 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov.